Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer

about

Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer

Item

http://www.wikidata.org/entity/Q58779429

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Lipolysis-stimulated lipoprote ...... eutic target in gastric cancer

@en

Lipolysis-stimulated lipoprote ...... eutic target in gastric cancer

@nl

type

Item

label

Lipolysis-stimulated lipoprote ...... eutic target in gastric cancer

@en

Lipolysis-stimulated lipoprote ...... eutic target in gastric cancer

@nl

prefLabel

Lipolysis-stimulated lipoprote ...... eutic target in gastric cancer

@en

Lipolysis-stimulated lipoprote ...... eutic target in gastric cancer

@nl

P1476

Lipolysis-stimulated lipoprote ...... eutic target in gastric cancer

@en

P2093

Kazuhiro Hanazaki

http://www.w3.org/2001/XMLSchema#string

Kiyokazu Nakajima

http://www.w3.org/2001/XMLSchema#string

Koji Tanaka

http://www.w3.org/2001/XMLSchema#string

Kosuke Hiramatsu

http://www.w3.org/2001/XMLSchema#string

Makoto Yamasaki

http://www.w3.org/2001/XMLSchema#string

Masahiro Koh

http://www.w3.org/2001/XMLSchema#string

Minoru Fujimoto

http://www.w3.org/2001/XMLSchema#string

Satoshi Serada

http://www.w3.org/2001/XMLSchema#string

Takahito Sugase

http://www.w3.org/2001/XMLSchema#string

Tetsuji Naka

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver

Trastuzumab--mechanism of action and use in clinical practice

THE METABOLISM OF TUMORS IN THE BODY

Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells.

Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.

The lipolysis stimulated receptor: a gene at last.

P31

scholarly article

P356

10.18632/ONCOTARGET.25952

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masaki Mori

Yuichiro Doki

P577

2018-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30250639

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

overexpression

P932

6152476

http://www.w3.org/2001/XMLSchema#string